Defibrillator Implant Articles & Analysis: Older
10 news found
Implicity’s AI-powered* platform allows healthcare professionals to better manage the growing streams of patient information produced by cardiac implantable electronic devices (CIEDs), such as pacemakers and implanted defibrillators. ...
Jude Medical in 1997 as Vice President, Systems Development as part of the company’s acquisition of Ventritex, Inc., a startup implantable defibrillator company where he had worked since 1987. He went on to become Senior Vice President, Clinical/Regulatory Affairs for the St. ...
” VT and ventricular fibrillation are important causes of sudden cardiac death, accounting for as many as 450,000 annual deaths in the US alone. Implantable cardiac defibrillators reduce the incidence of death in patients with arrhythmias, but are not curative, and can contribute to reduced quality of life in patients with recurring episodes. ...
After neurosurgery, Endomedix plans to target hemostasis indications for cardiac pacemaker and implanted defibrillator procedures. As an example of the potential scope of the technology, Endomedix has recently entered into a Cooperative Research And Development Agreement (CRADA) with the US Army using PLEXimine to develop a treatment for Ocular Projectile ...
Today, most people with VT are treated with implantable cardioverter defibrillators (ICDs), which monitor the heart rhythm and deliver a strong shock to the heart muscle to correct irregular pacing. ...
WALTHAM. Mass.. May 19,2020 - Thermedicak a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT): today announced that it has received Breakthrough Device Designation from the U.S. Food & Drug Administration (FDA) for its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate® catheter. The FDA Breakthrough Devices Program is intended to help ...
WALTHAM, Mass., May 8, 2020 - Thermedicak a developer of thermal-ablation systems to treat ventricular tachycardia (VT), announced that results from a First-in-Human Early Feasibility Study (EFS) using the new Durablate® catheter to treat VT were presented in the late-breaking clinical trial sessions at the Heart Rhythm Society (HRS) meeting today. Called the Saline Enhanced Radiofrequency ...
CHICAGO, May 12, 2017 - A new study examines the effectiveness of the Implantable Subcutaneous String Defibrillator (ISSD™), a flexible, string-shaped and first-ever rechargeable implantable cardioverter-defibrillator (ICD). ...
“We have a unique approach to adding proven antimicrobial capabilities to new or existing medical devices and implants, one that does not require external power sources, does not use drugs or other pharmaceutical agents and is durable enough to withstand the abrasive forces of screwing into bone. With these latest allowances, our IP portfolio has expanded to protect the use ...
This uniquely allows us to protect the broad range of our antimicrobial devices from orthopedic screws, hip and knee prostheses and cardiac implantable defibrillators and pacemakers to venous access indwelling catheters, sutures, surgical mesh and even surgical ...